PROFILES

Len Brandt

Chairman of the Board

As a member of Applied Biology’s Board of Directors, Mr. Brandt is integral to the Company’s strategic business objectives. Educated at Harvard, Len brings an extensive background in healthcare-related investment funds and experience from the venture capital field to Applied Biology.

As General Partner at Norwest Ventures, Mr. Brandt led the fund’s investment activity for ten years in all areas of healthcare. He was Partner and Co-founder of Embro Vascular, the dominant device technology for least invasive harvesting of saphenous veins for heart bypass surgery marketed by Boston Scientific, Guidant, and Macquet. Along side the founders of Home Diagnostics, Inc., the team successfully engineered a company turn-around that led to its sale to Nipro, Inc and a return to founders of almost $100MM. Additionally, Mr. Brandt was Founder and CEO of CNS Response, a big data translational database guiding medication selection in psychiatry. At CNS he defined the vision and core offering, was primary inventor on several patents leveraging off of the initial application, and organized all financings including reverse merge into public company with associated PIPE financing. Currently, he is involved with several young ventures seeking to “do well by doing good”.


Raj Airey

Board Member

With over 30 years experience in the healthcare industry, Raj Airey is veteran bringing a mix of international operating experience and venture building. His operational experience as an corporate executive in blue chip pharma (Pfizer, Baxter), serial entrepreneur, and venture builder supports Applied Biology in commercial strategy.

Mr. Airey brings to the team international and cross-cultural operating expertise, backed by a track record in turnaround business with complex market and leadership challenges. He has run businesses in the UK, Belgium, Hungary, Slovakia, Poland, Spain and India/South East Asia, organizations with 1000 employees and several manufacturing sites suppling products globally. During his corporate tenure as Managing Director at Pfizer and Baxter he has held several board roles representing industry interests including AMCHAM, several pharma associations and charitable organizations.

Raj has founded or co-founded several new ventures over the years. Directly after his graduate program in 1986, he cofounded Ultimate Expeditions which took groups trecking in the Himalayas and also began several healthcare ventures including WizzCare Home Health Solutions and HealthStart, India’s first healthcare accelerator.

He continues his work with healthcare innovation as a member of the review board for www.eithealth.eu, the world’s largest healthcare acceleration ecosystem created by the EU as PPP between top universities, industry, and healthcare accelerators in Europe.

Raj has a graduate degree from the London University and has undergone executive programs at Harvard Business School, INSEAD, and is an Accredited Executive Coach of International Coaching.


Prof. Andy Goren, MD

Board Member

Prof. Andy Goren has over 20 years of experience in research, development and commercialization of breakthrough therapeutics and diagnostics. Among the list of many firsts in dermatology, Prof. Goren was the first to develop a clinical genetic test for predicting androgenetic alopecia, the first to discover epigenetic markers predicting anti-androgen therapy response in female androgenetic alopecia, the first to develop a clinical acne vulgaris antibiotic response test based on P. Acnes bacterial genomics, and the first to develop a rapid test for predicting minoxidil response in androgenetic alopecia.

Prof. Goren is actively involved in the development, commercialization, and listing of several drugs and medical devices including new therapies for female pattern hair loss, chemotherapy induced alopecia, excessive hair shedding, female sexual dysfunction and COVID-19. His latest research involves the use of anti-androgen therapy for the treatment of COVID-19.

Prof. Goren currently serves as an External Medical Advisor and a Co-Researcher, Trichology Unit, Ramon y Cajal Hospital, Madrid, Spain, a Visiting Professor of Dermatology, Department of Dermatology and Venereology, Clinical Hospital Center Sestre Milosrdnice, Zagreb, Croatia, a Medical Doctor at the Skin & Cosmetic Research Dept., Shanghai Skin Disease Hospital, Shanghai, China and a Visiting Medical Doctor, Department of Dermatology and Venereology, L.T.M. Medical College Sion, Mumbai, India. Clinical Research Director at Samel Hospital, Manaus, Brazil. Prof. Goren has published dozens of peer-reviewed original medical research papers. He is an honorary as well as ordinary member of several dermatology societies world-wide as well as a regular lecturer at dermatology congresses around the world. He held numerous appearances and interviews on mainstream TV, radio, and prestigious newspapers.


Scott Olson, Esq.

Board Member

Scott Olson is a business and technology focused attorney with a practice concentration in general counsel and management services. Scott has expertise in commercial transactions, equity and debt financings, mergers and acquisitions, employment and services contracts and counseling, litigation management, settlement negotiations, entertainment transactions, environmental compliance, federal investigations, aviation law, government contracting, corporate governance, business counseling, licensing, public company reporting, and other general corporate representation.

Scott has represented a wide variety of companies ranging from private start-ups to mature public companies in various industries including genetics, aviation, creative agencies, software and technology, renewable energy and apparel.